Just a moment, the page is loading...

GSK-201546




201546, A repeat-dose study of batefenterol/FF (GSK961081/GW685698) compared with placebo in the treatment of COPD
batefenterol; fluticasone furoate
201546
NCT02573870
Pulmonary Disease, Chronic Obstructive
Phase 2
The data for this study is available in CDISC format.
June 2020